Abstract
Temozolomide is a relatively new chemotherapeutic agent frequently associated with selective CD4+ T-lymphocytopenia. Patients with cell-mediated immune defects are at higher risk for acquiring infections with Salmonella species. We describe the first case of disseminated salmonellosis in a patient treated with temozolomide.
Original language | English (US) |
---|---|
Pages (from-to) | 414-415 |
Number of pages | 2 |
Journal | Journal of Infection |
Volume | 57 |
Issue number | 5 |
DOIs | |
State | Published - Nov 2008 |
Keywords
- CD4 T-lymphocytopenia
- Salmonella
- Temozolomide
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases